NeuroSense Therapeutics Price Chart
NeuroSense Therapeutics Volume Chart
NeuroSense Therapeutics Market Segments
After Hours
+0.0348(+4.73%)
| Open | $0.7352 |
|---|---|
| Close | $0.7700 |
| Low | $0.7352 |
| Low Change | 0.0000 (0.00%) |
| High | $0.7700 |
| High Change | +0.0348 (+4.73%) |
| Range | $0.0348 |
| Volume | 4.067K |
| Dollar Volume | $3.13K |
Regular Trading Hours
-0.0021(-0.28%)
| Open | $0.7500 |
|---|---|
| Close | $0.7479 |
| Low | $0.7100 |
| Low Change | -0.0400 (-5.33%) |
| High | $0.7732 |
| High Change | +0.0232 (+3.09%) |
| Range | $0.0632 |
| Volume | 176.939K |
| Dollar Volume | $132.33K |
Premarket
*No Trades in Segment
After Hours Yesterday
+0.0309(+4.18%)
| Open | $0.7390 |
|---|---|
| Close | $0.7699 |
| Low | $0.7300 |
| Low Change | -0.0090 (-1.22%) |
| High | $0.7699 |
| High Change | +0.0309 (+4.18%) |
| Range | $0.0399 |
| Volume | 3.031K |
| Dollar Volume | $2.33K |
Regular Trading Hours Yesterday
-0.0103(-1.39%)
| Open | $0.7400 |
|---|---|
| Close | $0.7297 |
| Low | $0.7101 |
| Low Change | -0.0299 (-4.04%) |
| High | $0.7445 |
| High Change | +0.0045 (+0.61%) |
| Range | $0.0344 |
| Volume | 209.317K |
| Dollar Volume | $152.74K |
Premarket Yesterday
-0.0081(-1.11%)
| Open | $0.7313 |
|---|---|
| Close | $0.7232 |
| Low | $0.7200 |
| Low Change | -0.0113 (-1.55%) |
| High | $0.8200 |
| High Change | +0.0887 (+12.13%) |
| Range | $0.1000 |
| Volume | 15.551K |
| Dollar Volume | $11.25K |
NeuroSense Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.7483 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.7755 |
| 20 Day Moving Average (SMA20) | $0.8047 |
| 50 Day Moving Average (SMA50) | $0.7928 |
| 100 Day Moving Average (SMA100) | $0.8373 |
| 200 Day Moving Average (SMA200) | $0.9543 |
NeuroSense Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
NeuroSense Therapeutics Stock Splits
There have been no stock splits for NeuroSense Therapeutics (NRSN).
NeuroSense Therapeutics Dividends
There have been no dividends for NeuroSense Therapeutics (NRSN).